SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006073
Filing Date
2021-05-06
Accepted
2021-05-06 07:31:37
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20210331x10q.htm   iXBRL 10-Q 1226049
2 EX-31.1 edit-20210331xex31d1.htm EX-31.1 15789
3 EX-31.2 edit-20210331xex31d2.htm EX-31.2 15307
4 EX-32.1 edit-20210331xex32d1.htm EX-32.1 10160
  Complete submission text file 0001558370-21-006073.txt   5025917

Data Files

Seq Description Document Type Size
5 EX-101.SCH edit-20210331.xsd EX-101.SCH 24505
6 EX-101.CAL edit-20210331_cal.xml EX-101.CAL 41186
7 EX-101.DEF edit-20210331_def.xml EX-101.DEF 88701
8 EX-101.LAB edit-20210331_lab.xml EX-101.LAB 309500
9 EX-101.PRE edit-20210331_pre.xml EX-101.PRE 213498
10 EXTRACTED XBRL INSTANCE DOCUMENT edit-20210331x10q_htm.xml XML 994188
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 21895823
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences